Sterling Capital Management LLC Has $768,000 Holdings in Guardian Pharmacy Services, Inc. $GRDN

Sterling Capital Management LLC lessened its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 70.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,404 shares of the company’s stock after selling 48,616 shares during the quarter. Sterling Capital Management LLC’s holdings in Guardian Pharmacy Services were worth $768,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Ameritas Investment Partners Inc. increased its stake in shares of Guardian Pharmacy Services by 26.5% in the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after acquiring an additional 345 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Guardian Pharmacy Services during the second quarter valued at $43,000. State of Wyoming acquired a new stake in Guardian Pharmacy Services during the second quarter valued at $58,000. Strs Ohio purchased a new position in Guardian Pharmacy Services in the fourth quarter valued at about $75,000. Finally, Clearstead Advisors LLC grew its stake in Guardian Pharmacy Services by 196.3% in the fourth quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock valued at $79,000 after purchasing an additional 1,741 shares in the last quarter.

Guardian Pharmacy Services Price Performance

Shares of NYSE:GRDN opened at $42.23 on Thursday. The stock has a market capitalization of $2.10 billion, a P/E ratio of 50.87, a P/E/G ratio of 2.75 and a beta of 0.05. The business has a 50-day moving average of $39.02 and a two-hundred day moving average of $35.22. Guardian Pharmacy Services, Inc. has a fifty-two week low of $19.30 and a fifty-two week high of $44.00.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.05. Guardian Pharmacy Services had a return on equity of 30.72% and a net margin of 3.64%.The business had revenue of $336.60 million for the quarter, compared to analyst estimates of $329.89 million. During the same quarter in the prior year, the firm posted $0.22 EPS. The firm’s revenue for the quarter was up 2.2% on a year-over-year basis. As a group, research analysts expect that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Jefferies Financial Group began coverage on Guardian Pharmacy Services in a research note on Monday, March 30th. They set a “buy” rating and a $44.00 price target for the company. Bank of America increased their price objective on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Truist Financial raised their price objective on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a research report on Wednesday, June 17th. Zacks Research cut shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Finally, Oppenheimer boosted their target price on shares of Guardian Pharmacy Services from $38.00 to $43.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. Seven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $42.83.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.